Danville, PANCT06592820Now EnrollingIRB Ready

MASLD Clinical Trial in Danville, PA

Access cutting-edge masld treatment through this clinical trial at a research site in Danville. Study-provided care at no cost to qualified participants.

Sponsored by Olympus Corporation of the Americas

Quick Self-Assessment

See if you qualify for this Danville location

Preparing your pre-screening questions…

Expert Care in Danville

Access masld specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related masld treatment provided free

Apply for This Danville Location

Check if you qualify for this masld clinical trial in Danville, PA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Danville

    Convenient for PA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Danville site if eligible
  4. 4Begin participation

About This MASLD Study in Danville

This study shall be a prospective, multicenter, single arm, consecutive, interventional study conducted in a post-market setting using commercially available devices. Consecutive, eligible patients with clinical suspicion of MASLD or MASH reporting for an endoscopic ultrasound and liver biopsy for evaluation of fibrosis will be enrolled. EUS Shear Wave Elastography and Attenuation Imaging technologies will be compared to liver biopsy and FibroScan results and other non-invasive fibrosis screening modalities . The data collected during this study will be evaluated in accordance with the procedures set forth in the protocol. The main question\[s\] it aims to answer are: * Establish optimal cutoffs for EUS-SWE in reference to liver biopsies staging system for liver fibrosis * Evaluate the diagnostic performance of EUS-SWE compared to FibroScan (VCTE) and to other non-invasive fibrosis screening modalities (screening scores). Participants will undergo: * Endoscopic Ultrasound with Shear Wave Elastography (SWE) and Attenuation Imaging (ATI) * Liver biopsy * FibroScan

Sponsor: Olympus Corporation of the Americas

Who Can Participate

Inclusion Criteria

18 years of age or older
Willing and able to provide informed consent
Patient scheduled to undergo EUS with liver biopsy, either same session or separately; if separate, liver biopsy should be performed within 3 months of the EUS (either before or after) with no interval bariatric procedure/surgery or weight change of \>10% total body weight
Patient scheduled to undergo or have undergone FibroScan, which should be performed within 3 months of the EUS (either before or after) with no interval bariatric procedure/surgery or weight change of \>10% total body weight
Clinical suspicion of MASLD (hepatic steatosis with at least one of five cardiometabolic risk factors: 1) overweight or obesity, 2) elevated glucose, 3) low HDL-C, 4) hypertension, and/or 5) hypertriglyceridemia) or MASH (additionally characterized by the presence of inflammation and hepatocellular ballooning) with or without fibrosis, as determined by non-invasive or minimally invasive techniques (e.g. abdominal ultrasound, FibroScan)

Exclusion Criteria

Patients with surgically altered anatomy that precludes adequate endosonographic visualization of the liver parenchyma
Prior history of Hepatitis B or C infection
Decompensated cirrhosis (GI bleeding, ascites, encephalopathy)
Histological evidence of other concomitant chronic liver disease on biopsy
Inadequate liver biopsy
Prior history of or current excess alcohol consumption (\>140 g/week and \>210 g/week for females and males, respectively) documented in EMR

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Danville?

Yes, this clinical trial (NCT06592820) has an active research site in Danville, PA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

MASLD Treatment Options in Danville, PA

If you're searching for masld treatment options in Danville, PA, this clinical trial (NCT06592820) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Danville research site is actively enrolling participants for this clinical trial. You'll receive care from experienced masld specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all masld clinical trials near you to find additional studies recruiting in your area.

More Ankylosing Spondylitis Trials in Danville, PA

See all ankylosing spondylitis clinical trials recruiting in Danville — not just this study.

Browse Ankylosing Spondylitis Trials in Danville →

Browse More Trials by Condition

Ankylosing Spondylitis TrialsNon-Alcoholic Fatty Liver Disease TrialsAll Conditions →

Ready to Join in Danville?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Danville, PA